Logo image of PBH

PRESTIGE CONSUMER HEALTHCARE (PBH) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:PBH - US74112D1019 - Common Stock

63.15 USD
-0.75 (-1.17%)
Last: 1/28/2026, 8:04:50 PM
63.15 USD
0 (0%)
After Hours: 1/28/2026, 8:04:50 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to PBH. PBH was compared to 190 industry peers in the Pharmaceuticals industry. PBH gets an excellent profitability rating and is at the same time showing great financial health properties. PBH has a bad growth rate and is valued cheaply. With these ratings, PBH could be worth investigating further for value investing!.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • PBH had positive earnings in the past year.
  • In the past year PBH had a positive cash flow from operations.
  • Of the past 5 years PBH 4 years were profitable.
  • PBH had a positive operating cash flow in each of the past 5 years.
PBH Yearly Net Income VS EBIT VS OCF VS FCFPBH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

1.2 Ratios

  • PBH's Return On Assets of 5.83% is amongst the best of the industry. PBH outperforms 86.84% of its industry peers.
  • PBH's Return On Equity of 11.00% is amongst the best of the industry. PBH outperforms 85.79% of its industry peers.
  • With an excellent Return On Invested Capital value of 7.88%, PBH belongs to the best of the industry, outperforming 85.79% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for PBH is below the industry average of 12.83%.
Industry RankSector Rank
ROA 5.83%
ROE 11%
ROIC 7.88%
ROA(3y)3.39%
ROA(5y)4.11%
ROE(3y)6.22%
ROE(5y)8.76%
ROIC(3y)8.16%
ROIC(5y)7.67%
PBH Yearly ROA, ROE, ROICPBH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20

1.3 Margins

  • PBH has a better Profit Margin (18.09%) than 90.00% of its industry peers.
  • In the last couple of years the Profit Margin of PBH has grown nicely.
  • PBH has a Operating Margin of 31.00%. This is amongst the best in the industry. PBH outperforms 94.21% of its industry peers.
  • In the last couple of years the Operating Margin of PBH has remained more or less at the same level.
  • Looking at the Gross Margin, with a value of 56.10%, PBH is in the better half of the industry, outperforming 67.89% of the companies in the same industry.
  • PBH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 31%
PM (TTM) 18.09%
GM 56.1%
OM growth 3Y0.37%
OM growth 5Y-0.32%
PM growth 3Y-0.06%
PM growth 5Y5%
GM growth 3Y-0.79%
GM growth 5Y-0.88%
PBH Yearly Profit, Operating, Gross MarginsPBH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

7

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so PBH is destroying value.
  • PBH has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for PBH has been reduced compared to 5 years ago.
  • Compared to 1 year ago, PBH has an improved debt to assets ratio.
PBH Yearly Shares OutstandingPBH Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
PBH Yearly Total Debt VS Total AssetsPBH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.2 Solvency

  • An Altman-Z score of 2.57 indicates that PBH is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.57, PBH is in the better half of the industry, outperforming 64.74% of the companies in the same industry.
  • PBH has a debt to FCF ratio of 3.97. This is a good value and a sign of high solvency as PBH would need 3.97 years to pay back of all of its debts.
  • The Debt to FCF ratio of PBH (3.97) is better than 86.32% of its industry peers.
  • A Debt/Equity ratio of 0.55 indicates that PBH is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.55, PBH is not doing good in the industry: 66.32% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 3.97
Altman-Z 2.57
ROIC/WACC0.89
WACC8.82%
PBH Yearly LT Debt VS Equity VS FCFPBH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 3.70 indicates that PBH has no problem at all paying its short term obligations.
  • PBH has a Current ratio of 3.70. This is comparable to the rest of the industry: PBH outperforms 57.37% of its industry peers.
  • PBH has a Quick Ratio of 2.51. This indicates that PBH is financially healthy and has no problem in meeting its short term obligations.
  • With a Quick ratio value of 2.51, PBH perfoms like the industry average, outperforming 52.11% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.7
Quick Ratio 2.51
PBH Yearly Current Assets VS Current LiabilitesPBH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

3

3. Growth

3.1 Past

  • PBH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 13.15%, which is quite good.
  • Measured over the past years, PBH shows a quite strong growth in Earnings Per Share. The EPS has been growing by 8.88% on average per year.
  • Looking at the last year, PBH shows a decrease in Revenue. The Revenue has decreased by -0.02% in the last year.
  • PBH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.39% yearly.
EPS 1Y (TTM)13.15%
EPS 3Y3.72%
EPS 5Y8.88%
EPS Q2Q%-1.83%
Revenue 1Y (TTM)-0.02%
Revenue growth 3Y1.54%
Revenue growth 5Y3.39%
Sales Q2Q%-3.41%

3.2 Future

  • The Earnings Per Share is expected to grow by 4.13% on average over the next years.
  • Based on estimates for the next years, PBH will show a small growth in Revenue. The Revenue will grow by 1.15% on average per year.
EPS Next Y1.64%
EPS Next 2Y3.96%
EPS Next 3Y3.41%
EPS Next 5Y4.13%
Revenue Next Year-2.01%
Revenue Next 2Y0.22%
Revenue Next 3Y0.49%
Revenue Next 5Y1.15%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PBH Yearly Revenue VS EstimatesPBH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M 800M 1B
PBH Yearly EPS VS EstimatesPBH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 2 4

7

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 13.85, the valuation of PBH can be described as correct.
  • PBH's Price/Earnings ratio is rather cheap when compared to the industry. PBH is cheaper than 87.37% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of PBH to the average of the S&P500 Index (28.60), we can say PBH is valued rather cheaply.
  • The Price/Forward Earnings ratio is 12.90, which indicates a correct valuation of PBH.
  • Based on the Price/Forward Earnings ratio, PBH is valued cheaper than 83.68% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of PBH to the average of the S&P500 Index (25.83), we can say PBH is valued rather cheaply.
Industry RankSector Rank
PE 13.85
Fwd PE 12.9
PBH Price Earnings VS Forward Price EarningsPBH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PBH indicates a rather cheap valuation: PBH is cheaper than 87.89% of the companies listed in the same industry.
  • PBH's Price/Free Cash Flow ratio is rather cheap when compared to the industry. PBH is cheaper than 88.95% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.89
EV/EBITDA 10.52
PBH Per share dataPBH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 -20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The decent profitability rating of PBH may justify a higher PE ratio.
PEG (NY)8.44
PEG (5Y)1.56
EPS Next 2Y3.96%
EPS Next 3Y3.41%

0

5. Dividend

5.1 Amount

  • PBH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

PRESTIGE CONSUMER HEALTHCARE / PBH FAQ

What is the ChartMill fundamental rating of PRESTIGE CONSUMER HEALTHCARE (PBH) stock?

ChartMill assigns a fundamental rating of 6 / 10 to PBH.


Can you provide the valuation status for PRESTIGE CONSUMER HEALTHCARE?

ChartMill assigns a valuation rating of 7 / 10 to PRESTIGE CONSUMER HEALTHCARE (PBH). This can be considered as Undervalued.


What is the profitability of PBH stock?

PRESTIGE CONSUMER HEALTHCARE (PBH) has a profitability rating of 7 / 10.


What is the expected EPS growth for PRESTIGE CONSUMER HEALTHCARE (PBH) stock?

The Earnings per Share (EPS) of PRESTIGE CONSUMER HEALTHCARE (PBH) is expected to grow by 1.64% in the next year.